济南前列腺增生症状与治疗(济南早射秒射怎么办) (今日更新中)

If you're waiting on a furniture delivery, you're not alone. Some customers are reporting delays of four months or more assuming you can find the item you want in stock.Like everything else, the coronavirus pandemic has complicated distribution for the furniture business, and no one is immune to the problem of supply, demand and disruption."This has been a fundamental shock to the system,” says Michael Miller, chief operating officer at Convey, a technology company that helps retailers do better deliveries.“Our network has over 5 billion shipping events so we track every single data point from when a package leaves a fulfillment center, goes on a truck, goes to all of the different handoffs, and then reaches your door,” Miller added.Convey supports big, small and specialty retailers. Miller says the disruption in online business is complicated. And while things are getting better amid attempts to rebound and adjust to a new normal, there's a lot that can't be fixed overnight.“People are getting creative but the common denominator is they need more drivers, they need more trucks, they need more warehouses to keep up with this demand,” Miller said.Modloft, a Miami-based company that sells elite, contemporary and modern furniture, has 60% of its items on backorder, which company chief marketing officer Sean O’Brien said is “historic.”The “factory could have a delay, the transit company could have a delay bringing it into port, the port could have a delay, the warehouse could have a delay, there’s all sorts of places along the line where things can get backed up and we have to be good about communicating to the customer what’s happening and when,” O’Brien said.Modloft saw a good April and a historic summer for sales, breaking company records But, like all other businesses who are trying to get customers their goods as fast as possible, stock is a problem.“Customers are frustrated they can’t get a particular sofa or color they want for 90 days and this is happening at all brands,” O’Brien said. Customers “may have been to four other stores and come to us as the fifth and still frustrated with the same experience.”A-list celebrities are Modloft customers, like professional athletes and Grammy-nominated recording artists, but no matter your name, your wait time will be the same.“If you see something you like, grab it,” Miller said. “There are definitely supply shortages out there. I would pounce, not wait if you see something available. Secondly, pay close attention to what the retailer is telling you about the estimated delivery date. This is very, very important.”Convey says customers should sign up for alerts, make sure an estimated delivery date is clearly displayed before you buy, and be patient. Especially through the holiday shopping season. 2799

IMPERIAL BEACH, Calif. (KGTV) — The man whose body was discovered floating off-shore in the South Bay this week has been identified.Zabiullah Rahmani, 29, was found after he entered the water near an Imperial Beach lifeguard tower during the early morning hours of Aug. 4. Officials said Rahmani was at the beach with a friend when he entered the water. The friend lost sight of him and a short time later, his body was found by joggers in the 700 block of Seacoast Drive.Paramedics pronounced Rahmani dead at the scene.At the time of discovery, the San Diego Sheriff's Department said drugs or alcohol may have played a role in Rahmani's death, but the Medical Examiner report didn't immediately offer a cause of death. 728

In an op-ed in USA Today, White House staffer and Assistant to the President Peter Navarro denounced Dr. Anthony Fauci — the Director of the National Institute of Allergies and Infectious Diseases — as being "wrong about everything I have interacted with him on" when it comes to the coronavirus pandemic.In the column, Navarro claimed Fauci — who, until recently, was one of the most publicly available members of the coronavirus task force — did not properly warn the public about the dangers of COVID-19."When I warned in late January in a memo of a possibly deadly pandemic, the director of the National Institute of Allergy and Infectious Diseases was telling the news media not to worry," he wrote in his op-ed.Navarro claimed in the column that Fauci "fought against" President Donald Trump's decision to ban travel between the United States in China, despite ample evidence to the contrary.Finally, Navarro chastised Fauci for "flip-flopping on the use of masks."Fauci and several other government officials and agencies — including the CDC and Surgeon General Jerome Adams — initially recommended against the use of masks by the general public in the hopes of preserving a depleted national stockpile. However, Fauci has often advocated for the use of masks in public since the CDC changed its guidance in April, and has since admitted the inconsistent guidance was "was detrimental in getting the message across."Navarro's op-ed is just the latest attempt by White House officials to discredit the administration's top infectious disease expert in the middle of a pandemic. Over the weekend, reports emerged that an anonymous White House official told several news agencies that the administration was concerned about Fauci's track record on the virus.President Donald Trump has also publicly broken with Fauci on several points, including reopening schools, testing and the current outlook. On Monday, Trump maintained that he and Fauci have a "very good relationship."A New York Times poll indicates that 76% of Americans trusted Fauci to provide "accurate information" regarding COVID-19, while just 26% of Americans said the same for Trump. 2162

House Speaker Paul Ryan is not seeking re-election and will retire from Congress after this year, the Wisconsin Republican announced Wednesday."You realize something when you take this job," Ryan told reporters on Capitol Hill on Wednesday morning. "It's a big job with a lot riding on you ... but you also know this is not a job that does not last forever. ... You realize you hold the office for just a small part of our history. So you better make the most of it."He reminded reporters that he took the job "reluctantly" in 2015, when he took over from John Boehner, but Ryan also said he has no "regrets.""I like to think I've done my part," he said.Ryan's departure is a blow to GOP members who saw the Wisconsin Republican as a stable and policy-oriented leader in a party shaken by the tumultuous Donald Trump presidency. He has been a fundraising juggernaut ahead of the midterms this fall, and helped translate GOP agenda items into legislation such as a series of tax cuts and rolling back banking legislation put in place under Democrats.In his prepared remarks, Ryan focused on the tax law that passed last year as a key legacy he left behind and spoke at length about his desire to go home to Wisconsin to be home with his family. He said that the 2018 midterms and the chance that he wouldn't be speaker didn't factor at all into his decision to announce his retirement."None whatsoever actually," Ryan said.Trump, who has at times fought with congressional Republican including Ryan, tweeted praise for the speaker after his announcement."Speaker Paul Ryan is a truly good man, and while he will not be seeking re-election, he will leave a legacy of achievement that nobody can question. We are with you Paul!" Trump wrote. 1746

If you aren’t on this medication, chances are you know someone who is. It’s used to treat everything from pain to mood disorders and can be just what the doctor ordered for many.But now, there is mounting research uncovering misuse of and even a black market for this popular prescription.We’re talking about gabapentin. It’s approved for some types of seizures and nerve pain.Doctors also use it off-label to treat everything from insomnia to migraines to anxiety. Sixty-four million prescriptions of it were sold in the U.S. in 2016, up more than 60 percent from four years earlier.The thing is, experts say there is growing evidence it’s being abused, too. It’s even being sold on the streets under the name “Johnnys.” Dr. Joseph Insler, an addiction psychiatrist, says he’s seeing it all too often.“Sometimes, I've even experienced patients ask me for their “Johnnys” and then they'll, maybe, catch themselves and say, ‘No, no, no. I mean gabapentin',” he says.Why is this prescription being misused?“I think that some individuals may say that they use it to get high, and others may say they use it and get a drowsy effect. So, we're talking about the euphoria versus sedation, “ says Rachel Vickers Smith, Ph.D.Dr Vickers Smith wrote her dissertation on gabapentin abuse when studying drug abusers in Appalachia.“We found a nearly 3000 percent increase from 2008 to about 2014 in individuals reporting gabapentin abuse for the purposes of getting high,” she says.We wanted to see for ourselves, so we searched online. We easily found people talking about taking “Johnnys”, or gabapentin, to get high. There were also threads of people trying to spread awareness about the abuse.Experts say gabapentin is typically misused by substance abusers who mix it with other drugs.But, Dr. Insler says it’s also possible for people with legitimate prescriptions to misuse, too.He says, “If somebody’s taking excessively high doses or needing early refills” or if their mood changes, family members or clinicians should see these signs as red flags.A growing body of research shows the problem of abuse, especially among substance abusers is clear.  But some experts also worry about the number of prescriptions being handed out.A recent New England Journal of Medicine letter warned that “clinicians who are desperate for alternatives to opioids” are “increasingly prescribing gabapentin” and that “evidence suggests that some patients misuse, abuse or divert gabapentin.”Dr Rachel Vickers Smith says, “ I think that's why it's really important to get out the message,” about abuse, in general.Gabapentin is not a controlled substance or scheduled drug on the Federal level.We reached out to several government agencies. There was little information on potential abuse although the National Institute on Drug Abuse pointed us to existing research and the DEA says it is beginning to receive calls.Dr Vickers Smith says, “ I don't think that gabapentin abuse is on the CDC, DEA’s, NIDA’s radar, in part because we had this opioid epidemic.”All experts we talked to stress that this is NOT the next opioid epidemic, but they believe gabapentin abuse is something to watch closely and believe more research is needed.We contacted two of the manufacturers of gabapentin, including Pfizer, which told us, “Gabapentin is an important treatment option for their approved indications”. 3416

来源：资阳报